Related Experiment Video

Updated: May 15, 2026

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

CDA-2, a urinary preparation, inhibits lung cancer development through the suppression of NF-kappaB activation in

Xuan Wang1, Cui-Min Jiang, Hai-Ying Wan

  • 1Department of Pharmacy, Putuo People's Hospital, Shanghai, China.

Plos One
|January 4, 2013
PubMed

Insights

Cell differentiation agent 2 (CDA-2) and phenylacetylglutamine (PG) inhibit lung tumor growth and reduce inflammation by suppressing NF-κB activation via TLR2:TLR6 signaling in myeloid cells.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Cell differentiation agent 2 (CDA-2) exhibits anti-proliferative and pro-apoptotic effects on cancer cells.
  • The precise mechanisms underlying CDA-2's tumor inhibitory actions, particularly in lung cancer, remain largely unelucidated.

Purpose of the Study:

  • To investigate the efficacy of CDA-2 and its component phenylacetylglutamine (PG) in inhibiting lung tumor development.
  • To elucidate the molecular mechanisms by which CDA-2 and PG exert their anti-tumor effects in lung cancer, focusing on inflammation and immune signaling.

Main Methods:

  • Lewis lung carcinoma (LLC) cells were used to establish lung tumors in C57BL6 mice.
  • Analysis of proliferation and apoptosis markers (Bcl-2, Bcl-XL, cIAP1, Survivin, PCNA, Ki-67, TUNEL assays).
  • Assessment of NF-κB DNA-binding activity, inflammatory cytokine release (TNFα, IL-6, KC), and Toll-like receptor (TLR) expression (TLR2, TLR6, CD14) in myeloid cells.

Main Results:

  • CDA-2 and PG significantly reduced metastatic lung tumor growth and increased survival in a dose-dependent manner.
  • Treatment with CDA-2 and PG suppressed proliferation and induced apoptosis in cancer cells.
  • CDA-2 and PG decreased NF-κB activation and inflammatory cytokine release in lung cancer cells and myeloid cells.
  • CDA-2 and PG reduced the expression of TLR2, TLR6, and CD14 in bone-marrow-derived macrophages (BMDM).
  • Overexpression of TLR2 in BMDM abrogated the inhibitory effects of CDA-2 and PG on NF-κB activation and cytokine production.
  • TLR2:TLR6 complexes were identified as mediators of NF-κB inactivation by CDA-2.

Conclusions:

  • CDA-2 and PG effectively inhibit lung tumor development by reducing inflammation.
  • The anti-tumor mechanism involves the suppression of NF-κB activation in myeloid cells.
  • Modulation of TLR2 signaling pathways is crucial for the observed anti-lung cancer effects of CDA-2.

More Related Videos

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells11:06

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells

Published on: May 20, 2015

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...